Cargando…

Eptacog Alfa (Activated) Is Physically and Chemically Stable over 24 Hours when Administered as Bolus Injections in an Automated Infusion Pump

Introduction Eptacog alfa (activated) is a recombinant activated factor VII (rFVIIa) used for the treatment and prevention of bleeding episodes in patients with congenital hemophilia with inhibitors. Frequent dosing requirements make the use of an automated bolus infusion pump a promising alternati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rexen, Per, Jensen, Jane Taaftegaard, Schwerin, Nina Bjorn, Kozina, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524905/ https://www.ncbi.nlm.nih.gov/pubmed/31249981 http://dx.doi.org/10.1055/s-0039-1678684

Ejemplares similares

Effect of intravenous dexmedetomidine administered as bolus or as bolus-plus-infusion on subarachnoid anesthesia with hyperbaric bupivacaine
por: Kavya, Upadhya R, et al.
Publicado: (2018)

Eptacog-α/prednisone/rituximab: No response: case report
Publicado: (2021)

Low-cost, programmable infusion pump with bolus mode for in-vivo imaging
por: Kujawa, Maciej, et al.
Publicado: (2021)

Hemodynamic effects of carbetocin administered as an intravenous bolus or infusion during cesarean delivery
por: Kwon, Kihyug, et al.
Publicado: (2020)

Successful use of recombinant activated factor VII (eptacog alfa, Novoseven®) in a refractory bleeding during pediatric cardiac surgery: a case report
por: Ishihara, Mariko, et al.
Publicado: (2015)

Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer
por: Taflin, Helena, et al.
Publicado: (2022)

A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma
por: Clamp, A R, et al.
Publicado: (2003)

Feasibility of using the Automated Self-Administered 24-hour (ASA-24) dietary assessment tool in older adults
por: Spangler, Hillary B, et al.
Publicado: (2023)

Extended drotrecogin alfa (activated) therapy in patients with persistent requirement for vasopressor support after 96-hour infusion with commercial drotrecogin alfa (activated)
por: Dhainaut, J, et al.
Publicado: (2008)

Safety, pharmacokinetics and CNS distribution of tralesinidase alfa administered via intracerebroventricular infusion to juvenile cynomolgus monkeys
por: Pinkstaff, Jason, et al.
Publicado: (2023)

Exploration of an Alarm Sensor to Detect Infusion Failure Administered by Syringe Pumps
por: Wieduwilt, Florian, et al.
Publicado: (2022)

Application of the Automated Self-Administered 24-Hour (ASA24) Dietary Assessment Tool's New Carbon Footprint Dataset
por: Faust, Erika, et al.
Publicado: (2022)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
por: Marian, Moazez J., et al.
Publicado: (2017)

Comparison of the Effects of Intravenously Bolus‐administered Endothelin‐1 and Infused Angiotensin II on the Subcutaneous Tumor Blood Flow in Anesthetized Rats
por: Tanda, Shigeru, et al.
Publicado: (1991)

Phase I and Pharmacokinetic Study of Paclitaxel by 24‐Hour Intravenous Infusion
por: Tamura, Tomohide, et al.
Publicado: (1994)

The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors
por: Escobar, Miguel, et al.
Publicado: (2021)

Predicting Perceived Problems in Self-Administered 24-Hour Dietary Recalls: A Quantitative Think-Aloud Study Comparing Automated Self-Assisted 24-Hour Dietary Assessment Tool (ASA24(®)) and INTAKE24© in University Students
por: Mackenzie, Katlyn M., et al.
Publicado: (2022)

A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.
por: Anderson, H., et al.
Publicado: (1993)

Comparison of the NHANES dietary screener questionnaire to the Automated Self-Administered 24-Hour Recall for Children in the Healthy Communities Study
por: Hewawitharana, Sridharshi Chintha, et al.
Publicado: (2018)

Exploratory in vitro evaluation of thrombin generation of eptacog beta (recombinant human fviia) and emicizumab in congenital haemophilia A plasma
por: Grandoni, Jerry, et al.
Publicado: (2021)

Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors
por: Pipe, Steven W., et al.
Publicado: (2022)

The intermittent bolus infusions of rapid infusion system caused hypothermia during liver transplantation
por: Kim, Gaab-Soo, et al.
Publicado: (2013)

A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia
por: Schimmer, Aaron D., et al.
Publicado: (2014)

Stroke Recovery in Rats after 24‐Hour–Delayed Intramuscular Neurotrophin‐3 Infusion
por: Duricki, Denise A., et al.
Publicado: (2018)

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
por: Ribas, Antoni, et al.
Publicado: (2012)

Replacement of oxytocin bolus administration by infusion: influences on postpartum outcome
por: Löytved-Hardegg, Julia J., et al.
Publicado: (2015)

Comparison of Intravenous Bolus and Infusion of Dexmedetomidine on Characteristics of Subarachnoid Block
por: Vatsalya, Tripti, et al.
Publicado: (2018)

Acute onset anterior uveitis after darbepoetin alfa infusion
por: Li, Jonathan, et al.
Publicado: (2015)

Recombinant FVIII Products (Turoctocog Alfa and Turoctocog Alfa Pegol) Stable Up to 40°C
por: Napolitano, Mariasanta, et al.
Publicado: (2021)

Validation of a self-administered web-based 24-hour dietary recall among pregnant women
por: Savard, Claudia, et al.
Publicado: (2018)

Phase I trial with pharmacokinetics of CB10-277 given by 24 hours continuous infusion.
por: Foster, B. J., et al.
Publicado: (1993)

Rebound hypotension following terlipressin bolus infusion can be prevented by continuous low-dose infusion of terlipressin
por: Lange, M, et al.
Publicado: (2007)

1547. Modeling Pharmacokinetics and Pharmacodynamics of Meropenem Utilizing a Novel Infusion Method of Bolus to Prolonged Infusion
por: Moore, Sarah E, et al.
Publicado: (2019)

Extracellular volume fraction measured by MOLLI: slow infusion versus bolus
por: Schelbert, Erik, et al.
Publicado: (2011)

Continuous infusion versus intermittent bolus of ceftazidime for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2003)

Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems
por: Freckmann, Guido, et al.
Publicado: (2019)

Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients
por: Chantzichristos, Dimitrios, et al.
Publicado: (2008)

Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis
por: Yu, Zhenwei, et al.
Publicado: (2018)

Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion
por: Fleming, Gini F, et al.
Publicado: (2015)

Combined Programmed Intermittent Bolus and Patient-Controlled Bolus Is a More Favorable Setting for Epidural Pain Relief Than Continuous Infusion
por: Liu, Shih-Kai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ca4ekqcv539lgvqev0iuv7hdf6